Total Funding
51
5
Total FundingVenture - Series Unknown raised
Growth Score 51 in past quarter
-6 pts
Heat Score 5 in past quarter
-14 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
266950
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
- Venkat Krishnan: Founder, President & CEO
- Gaurav Mehrotra: CFO & EVP Commercial Operations
About the Company
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships. It is licensed to do business in the United States and is accomplished in the areas of product development, regulatory affairs, quality management, sales and distribution, and supply chain management. Today, Bionpharma is one of the
largest suppliers of soft gel capsules in the US market with a strong presence in both the prescription and over-the-counter markets.
Launched in 2014, BionPharma was founded by a team of executives and professionals with years of cumulative experience in the generics industry. It is based in Princeton, New Jersey, and with offices in Raleigh, North Carolina.
